Preview

Summary: Selective Business Entity For Cure Of Cancer

Satisfactory Essays
Open Document
Open Document
639 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Summary: Selective Business Entity For Cure Of Cancer
M E M O R A N D U M

TO: Client
FROM:
DATE: November 16, 2011
RE: Suggestive Business Entity for Cure of Cancer Question Presented What business entity would be best suited in order to create the enterprise for the client’s scientific cure of cancer, while keeping his main interests in mind: to get assistance in running the business portion of the enterprise, while limiting his personal liability; and providing investors with the most profit possible while limiting the scope of the amount of how many people that will eventually be involved?

Brief Answer A C Corporation will likely suit the needs of the clients’ interest in creating his business enterprise of creating the cure for cancer.

Facts Based on the information provided by the client, he wants to manage the scientific aspect of the business and hire business professionals to run the enterprise and raise additional funds. In addition, he wants to limit his liability in the enterprise and wants to limit the scope of how many investors would be involved.

Discussion
…show more content…
Because of this, C Corporation would be most beneficial. If the client brought on his main investors as limited partners and then they ended up making significant management decisions while he developed the science, they would be treated as general partners for liability reasons. Also, the client did not say exactly that he did not want investors to be liable, only limit the scope of how many people would be involved, he did say that he wanted to limit his personal liability. Therefore, C Corporation would be most beneficial because the client and his investors would have limited

You May Also Find These Documents Helpful

  • Satisfactory Essays

    Trueblood Case 09 2

    • 804 Words
    • 2 Pages

    Company XYZ is an unrelated third-party private equity investor with no prior relationship or business operations related to Pharmagen…

    • 804 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Cetuximab Case Study

    • 316 Words
    • 2 Pages

    Our company want to major in follow on biologics of bifunctional antibodies. The bifunctional antibodies market is still infancy and certainly first companies enter to this flied will have a competitive advantage over other biopharma companies. Therefor, we want to be one of the first companies starting in the field of follow on bifunctional antibodies. Nonetheless, many big pharma companies attracted to biosimilar market since they are in patent cleft thus they are trying to collaborate with other companies to produce biosimilar. For example, Pfizer established a collaborative with Biocon to produce biosimilar for insulin. As a new company, Innovace want to collaborate with biopharma company in China to magnify our business and brand name so then we can stand in the biosimilar…

    • 316 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    We have been requested to review and present to you our recommendations for the start of your new Pharmaceutical/Biotech Consulting Company. To begin, we would like to review the information that we have been given from you to KMCE&A. We understand that you have a background as a business executive as well as a scientific background. Your business plan states you are starting up a consulting company that will handle R&D monitoring for other companies that are in the Pharmaceutical/Biotech Industry. Your client base is mostly in the New Jersey and Pennsylvania area but hope to eventually expand to a global customer base. Your main investments will be in salaries in that as a services industry you will have minimal asset investments. Your personal preference is to have no personal liability. You would like to keep the ownership small and retain the majority ownership of 50% to 60% so that you can keep control of the decision making. However you are open to issuing stock if the funding of your business would benefit from this over financing through debt. You also expect to have a loss of approximately $25,000 in the first year due to start up costs and become profitable by year two. You initially will have three employees joining you at the start of the business. Two employees, Scott & Kate, will be contributing services of an IT specialist and a marketing/public relations as well as a program manager. The third member, Todd, who is an attorney, will not only contribute legal services but also an initial investment of $50,000. We also understand that you have $200,000 of personal funds to invest as well as have obtained an additional $500,000 in financing through securing your own personal assets.…

    • 5105 Words
    • 17 Pages
    Powerful Essays
  • Good Essays

    Correct Answer: One advantage of forming a corporation is that equity investors are usually exposed to less liability than in a regular partnership.…

    • 1806 Words
    • 8 Pages
    Good Essays
  • Powerful Essays

    LiverDerm, LLC, LLC meets the definition of a group practice as described by the Stark Law…

    • 989 Words
    • 4 Pages
    Powerful Essays
  • Powerful Essays

    SCR Case Study 1

    • 821 Words
    • 5 Pages

    Three IT professionals founded the company. They wanted to create a new kind of IT firm. This vision seems to be very client oriented.…

    • 821 Words
    • 5 Pages
    Powerful Essays
  • Satisfactory Essays

    Submit a paper of no more than 1,400 words with your research results and recommendations for the client.…

    • 640 Words
    • 3 Pages
    Satisfactory Essays
  • Better Essays

    Eco 561 Wk 4

    • 1761 Words
    • 8 Pages

    In the realm of pharmaceutical drug sales, there are many players in the market. Many of these companies have a large inventory of drugs that they manufacture. The subdivision of the pharmaceutical market that draws the most revenue is oncology medications. Many companies will specialize in drugs for only one type of cancer, or sometimes with only one drug period. The cost of research and development in this field is much higher than any other disease subdivision. With many companies focusing on specific treatment plans there is a real opportunity to corner the market. The sale of oral medication is on the rise, by getting ahead of the generic sales of these oral agents, the company can establish itself at the forefront of contemporary cancer treatment. The following will point out ways to boost revenue, determine maximizing profit strategies, and creating barriers to establish this company as the leader in oncologic pharmaceutical sales.…

    • 1761 Words
    • 8 Pages
    Better Essays
  • Satisfactory Essays

    b) My recommendation for forming CCS is LLC. I chose LLC because the organizing business members may reduce their individual tax liabilities by operating as a LLC. CCS should be concerned about FICA and self-employment taxes. LLCs must pay self-employment taxes. As the business grows past 3-4 years, I recommend CCS to look at the possibility of switching to and S Corporation. At this point, compensation needs may have reduced and the members would wish to fully benefit from self-employment tax removal.…

    • 559 Words
    • 3 Pages
    Satisfactory Essays
  • Good Essays

    Week 6 - You Decide

    • 894 Words
    • 4 Pages

    There are a number of different forms of organizations for Penelope, Mark, and John to choose. The four main ones are a partnership, Limited Liability Corporation (LLC), S Corporation, or C Corporation.…

    • 894 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    Week 6 You Decide

    • 1981 Words
    • 6 Pages

    There are so many options available as to how they can structure the new business. The appropriate business entity for any individual(s) will depend on their particular facts and circumstances.…

    • 1981 Words
    • 6 Pages
    Powerful Essays
  • Good Essays

    This year, about 580,350 US residents are expected to die of cancer – that’s nearly 1,600 people a day. Cancer is the second most common cause of death in the United States, exceeded only by heart disease. Cancer accounts for nearly 1 out of every 4 deaths in the United States. Drug prices are becoming a developing issue for every disease, especially for people who are uninsured. But the cost of cancer has shown an alarming increase and is steadily growing. As a list of more advanced biotech drugs become available the cost for treatment rounds costing $100,000, or even more, are no longer a rarity. With each new drug means more research which in turn means more money. Patients’ living longer is great news but also means they need treatment for longer periods which also increases cost. Prices reflect manufacturers’ years of research and development investment. Also, many drug companies donate a certain amount of medication to prescription-assistance programs that provide them for free to patients who otherwise couldn’t pay. This is a great program but is also extremely costly and directly contributes to the cost.…

    • 498 Words
    • 2 Pages
    Good Essays
  • Good Essays

    |(Charity) |have cancer. Their aim is to save lives from cancer. They |profit. |size national business with over |national business. National businesses |…

    • 794 Words
    • 4 Pages
    Good Essays
  • Satisfactory Essays

    My source of power is that our firm is oldest and well established with mid-sized staff and a moderately sized laboratory. Turbo concentrates in cancer-related technologies and has a reputation for steady output and reliable products. Turbo contributes more value than United. Moreover, if stockman and I cooperate, we could get the highest fund that is $440,000.…

    • 391 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Health Care Cost

    • 1668 Words
    • 7 Pages

    But with that will come some big costs. The IMS Institute for Healthcare Informatics expects cancer treatment costs to hit $150 billion by 2020, up from $107 billion in 2015. The “Cancer Business” has become so big that large companies are dedicated to developing cancer treatments with price control often taking a backseat. For example, pharmaceutical giant Novartis just split out its oncology business into a separate branch from its other disease areas. Cancer is a complicated disease that requires a whole web of decision-making, which ultimately leads to higher costs of cancer treatment. (Ramsey, 2016)…

    • 1668 Words
    • 7 Pages
    Good Essays